MADISON, Wis.--(BUSINESS WIRE)--Roche NimbleGen, a company of Roche announced today the launch of comparative genomic hybridization (CGH) arrays and services for the high-resolution mapping of genomic copy-number differences based on the company’s new 2.1 million-probe HD2 platform.
